TIAGABINE HYDROCHLORIDE
NDC 62756-200, TIAGABINE HYDROCHLORIDE, tablet, film coated, from Sun Pharmaceutical Industries, Inc..
- Product NDC
- 62756-200
- Status
- Listed
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA077555
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62756-200 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TIAGABINE HYDROCHLORIDE2 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62756-200-18 | 62756020018 | 1000 TABLET, FILM COATED in 1 BOTTLE (62756-200-18) |
| 62756-200-83 | 62756020083 | 30 TABLET, FILM COATED in 1 BOTTLE (62756-200-83) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7eeb2d81-c5d7-46a0-aa5c-149b55df71bd
Use it
Look up 62756-200 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62756-200 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62756-200. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.